New Findings in Breast Cancer Described from Yale Cancer Center [Trastuzumab emtansine: determining its role in management of HER2(+) breast cancer]

MLA

“New Findings in Breast Cancer Described from Yale Cancer Center [Trastuzumab Emtansine: Determining Its Role in Management of HER2(+) Breast Cancer].” Biotech Week, 25 Apr. 2018, p. 268. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.535707139&authtype=sso&custid=ns315887.

APA

New Findings in Breast Cancer Described from Yale Cancer Center [Trastuzumab emtansine: determining its role in management of HER2(+) breast cancer]. (2018, April 25). Biotech Week, 268.

Chicago

Biotech Week. 2018. “New Findings in Breast Cancer Described from Yale Cancer Center [Trastuzumab Emtansine: Determining Its Role in Management of HER2(+) Breast Cancer],” April 25. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.535707139&authtype=sso&custid=ns315887.